PerspectiveImmunology

The Shape of Things to Come

See allHide authors and affiliations

Science  15 Jun 2007:
Vol. 316, Issue 5831, pp. 1574-1576
DOI: 10.1126/science.1144483

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Mechanistic understanding of how ligands can fine-tune the immune response may lead to better vaccine adjuvants.